Indogulf Cropsciences Q2FY27: Revenue Up 3% to ₹2,558 Cr, PAT Jumps 24% to ₹257 Cr
Indogulf Cropsciences reported Q2 FY27 revenue of ₹2,558 crore, up 3% YoY, with PAT rising 24% to ₹257 crore. H1 FY27 revenue was ₹4,243 crore, while PAT increased 14% to ₹281 crore. The company aims to expand its biologicals portfolio and global reach.
The announcement pertains to the company's financial performance, which is a key factor for investors. The reported growth in revenue and profit, coupled with strategic future plans, can significantly influence investor sentiment and the company's stock.
The company has shown positive growth in PAT for both the quarter and half-year, along with significant improvements in EBITDA margins, indicating improved operational efficiency and profitability. The forward-looking statements regarding expansion and innovation also contribute to a positive sentiment.
Indogulf Cropsciences Limited has announced its financial results for the second quarter and first half of the fiscal year 2026-27. The company reported a 3% year-on-year increase in revenue for Q2 FY27, reaching ₹2,558 crore (₹2,557.78 million). EBITDA saw a significant jump of 27% to ₹406 crore (₹405.62 million), with EBITDA margins improving by 300 basis points to 15.9%. Profit After Tax (PAT) for the quarter rose by 24% to ₹257 crore (₹256.84 million), and PAT margins improved by 100 basis points to 6.6%.
For the first half of FY27 (H1 FY27), revenue stood at ₹4,243 crore (₹4,243.23 million), a marginal decrease of 3% YoY. However, EBITDA for H1 FY27 increased by 20% to ₹501 crore (₹501.17 million), with EBITDA margins improving by 220 basis points to 11.8%. PAT for the first half grew by 14% to ₹281 crore (₹280.98 million), and PAT margins improved by 170 basis points to 10.0%.
The company's revenue mix for H1 FY27 shows Crop Protection contributing 85%, Biologicals at 6%, and Plant Nutrients at 5%. The revenue streams are diversified across B2C (59%), B2B (35%), and Exports (6%). The company is focused on expanding its biologicals and sustainable portfolio, increasing high-margin product contribution, deepening farmer engagement through an advisory-led model, accelerating global expansion, strengthening operational excellence, and driving innovation-led growth.
The investor presentation was scheduled to be uploaded on the company's website and was made available following the earnings call on November 4, 2026, at 2:00 PM IST.
What to do with a filing like this
Indogulf Cropsciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Indogulf Cropsciences Limited. Read the original for the full detail.